Mantra Pharma maintains steady growth
BROSSARD, May 16, 2023- Mantra Pharma maintains impressive growth completing 39 product launches, including all strengths, in the past 16...
Mantra Pharma Introduces the First Generic Alternative to CLAVULIN® (GSK) in Canada
BROSSARD, QC, December 19, 2022 - Following an increase in cases of respiratory viruses, Canada is currently experiencing supply issues...
Mantra Pharma solidifies its position in the Canadian industry by launching M-Amoxi Clav
Quebec pharmaceutical company Mantra Pharma is pleased to announce the approval of the all-new M-Amoxi Clav (400 mg/57 mg per...
Expansion continues with the launch of 6 products, including M-Apixaban
Since the beginning of 2022, Mantra Pharma has launched several new products, planning to offer no less than six new...
Mantra Pharma opens its new distribution centre
It is with great pride that Mantra Pharma's Lévis team opened its new warehouse and business location The building already...